Published online Jul 16, 2021. doi: 10.12998/wjcc.v9.i20.5420
Peer-review started: March 4, 2021
First decision: April 14, 2021
Revised: April 25, 2021
Accepted: May 26, 2021
Article in press: May 26, 2021
Published online: July 16, 2021
Processing time: 124 Days and 11.2 Hours
The coronavirus disease 2019 (COVID-19) epidemic is a major public health emergency characterized by fast spread, a wide range of infections, and enormous control difficulty. Since the end of December 2019, Wuhan has become the first core infection area of China's COVID-19 outbreak. Since March 2020, the domestic worst-hit areas have moved to the Heilongjiang Province due to the increased number of imported COVID-19 cases. Herein, we reported the major COVID-19 outbreak, which caused a rebound of the epidemic in Harbin, China. After the rebound, different levels of causes for the recurrence of COVID-19, including city-level, hospital-level, and medical staff-level cause, were investigated. Meanwhile, corresponding countermeasures to prevent the recurrence of the epidemic were also carried out on the city level, hospital level, and medical staff level, which eventually showed the effect of infection control function in a pandemic. In this study, we described the complete transmission chain, analyzed the causes of the outbreak, and proposed corresponding countermeasures from our practical clinical experience, which can be used as a valuable reference for COVID-19 control.
Core Tip: The coronavirus disease 2019 (COVID-19) epidemic is a major public health emergency characterized by fast spread, a wide range of infections, and enormous control difficulty. We reported the major COVID-19 outbreak, which caused a rebound of the epidemic in Harbin, China. After the rebound, different levels of causes for the recurrence of COVID-19, including city-level, hospital-level, and medical staff-level cause, were investigated. Meanwhile, corresponding countermeasures to prevent the recurrence of the epidemic were also carried out on the city level, hospital level, and medical staff level, which eventually showed the effect of infection control function in a pandemic. We described the complete transmission chain, analyzed the causes of the outbreak, and proposed corresponding countermeasures from our practical clinical experience, which can be used as a valuable reference for COVID-19 control.
- Citation: Chen Q, Gao Y, Wang CS, Kang K, Yu H, Zhao MY, Yu KJ. Exploration of transmission chain and prevention of the recurrence of coronavirus disease 2019 in Heilongjiang Province due to in-hospital transmission. World J Clin Cases 2021; 9(20): 5420-5426
- URL: https://www.wjgnet.com/2307-8960/full/v9/i20/5420.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v9.i20.5420
With the continuous decline in the number of newly confirmed and existing coronavirus disease 2019 (COVID-19) patients in China, the epidemic can be considered as successfully conquered. Consequently, the current focus is on the strict control of imported cases from overseas and the prevention of their spread. In April 2020, a clustering severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections occurred in two general tertiary hospitals in Harbin city, resulting in 66 newly confirmed patients and 21 asymptomatic patients, among whom 8 patients were the medical staff. These confirmed and asymptomatic COVID-19 patients have come in contact with other patients, family caregivers, and medical staff as they were treated in the same ward with the other patients. The recurrence of the epidemic led to the complete closure of the Second Hospital of Harbin on April 20, and even caused the inter-provincial transmission to Liaoning Province and the Inner Mongolia Autonomous Region. In these two hospitals, the in-hospital infection seriously affected residents' normal lives and disrupted the plan for the resumption of work and production. This study aimed to describe the complete transmission chain, analyze the causes of the outbreak, and propose corresponding countermeasures based on our practical clinical experience that can, later on, be used for reference.
This transmission chain's core patient was an 87-year-old male with a stroke who was admitted to the Second Hospital of Harbin (Hospital 1 in the Figure 1) from April 2 to April 6. The patient was transferred to the respiratory department in the First Affiliated Hospital of Harbin Medical University (Hospital 2 in the Figure 1) due to fever during hospitalization. He came in contact with a number of people 4 d before admission during dinner, including passer B. There was a clear contact history between passer B and passer A, who was later on diagnosed as COVID-19 confirmed patient. Passer A was a neighbor of a United States returned compatriot who tested positive for the two consecutive serum immunoglobulin G (IgG) antibody against SARS-CoV-2. The schematic diagram of the complete transmission chain is shown in Figure 1.
The returned compatriot, a neighbor of passer A, returned from the epidemic area in the United States and underwent detection of SARS-CoV-2 nucleic acids two times within 14 d after entry, each time testing negative. At present, the main detection method for SARS-CoV-2 includes the detection of viral nucleic acids on oropharyngeal and/or nasopharyngeal swabs[1,2]. However, in practice, false-positives and negatives have been reported to occur[3-5]. This imported case provided further support for the premise that if two consecutive negative results of viral nucleic acid on respiratory samples were taken as the exclusion criterion, they would still lead to about 10% missed diagnosis, eventually resulting in the spread of the epidemic[6]. On the 22nd day after entry, the third detection of SARS-CoV-2 nucleic acids was still negative, but the serum IgG antibody was positive and remained to be positive on the next day. Therefore, this United States returned compatriot was identified as being previously infected with COVID-19. Dr. Zhang, the president of Harbin Medical University, pointed out that the whole genome sequence of SARS-CoV-2 in 21 patients from two batches of samples was 99.99% identical and thus from the same transmission chain. Furthermore, the genome sequence of SARS-CoV-2 in this transmission chain was different from that previously detected in the Chinese population through gene sequencing analysis. Considering the evidence of genome sequencing analysis and epidemiological investigation, the returned compatriot from the United States was identified as the outbreak's infection source.
SARS-CoV-2 has been defined as a highly pathogenic human coronavirus. Human-to-human spread via droplets, aerosol, contaminated hands, or surfaces contact among close contacts has been identified as the main transmission way[7-20], especially in closed environments. The aforementioned returned compatriot, identified as the infection source in this transmission chain, shared the same elevator with passer A, and may have the possibility of engaging in face-to-face contact.
The emergency response level of epidemic prevention and control in Heilongjiang Province had been adjusted from the second-level response to the third-level response from 18:00 on March 25. The gradual improvement in the COVID-19 epidemic and the urgent desire to normalize life and resume work and production reduced people's vigilance against the recurrence of the epidemic. Social dining, which included core patient and passer B, took place on March 29. In addition, the returned compatriot in the transmission chain returned to Harbin from the United States on March 19. The quarantine measure of entry personnel implemented at that time was home quarantine for 14 d. On the 8th and 9th d after suspending home quarantine, the serum IgG antibody was positive two consecutive times. This occurrence suggests the quarantine measure of entry personnel at that time was worth discussing and improving.
Hospitals, especially general tertiary hospitals, are the first place for COVID-19 patients to seek medical support. Consequently, they are highly populated and with the highest risk of in-hospital infection spread[11], which is consistent with previous reports on SARS-CoV and Middle East respiratory syndrome CoV[12-14]. Still, this was not reflected in the management policy of the two hospitals at that time due to insufficient awareness and lack of vigilance. First of all, when the core patient developed a fever and was transferred to the First Affiliated Hospital of Harbin Medical University, there was no timely detection of SARS-CoV-2 nucleic acid. Consequently, this resulted in the failure to identify COVID-19 patients as early as possible and to prevent timely in-hospital infection spread. Moreover, there was no strict limit on the number of admitted patients and their family caregivers, which further facilitated the outbreak of the epidemic and propagation out of the hospital. Also, the mobility of admitted patients and their family caregivers across different rooms and wards was not strictly controlled. Finally, undiagnosed patients with fever and pulmonary imaging changes were not arranged in a single isolation area similar to the buffer zone. Obviously, the kind of confined space in the hospital ward is highly susceptible to cause the spread of in-hospital infection. Numerous omissions in hospital management policies have resulted in the disastrous consequence of 1-to-87.
Like most other people in Harbin city, most medical staff believed that the COVID-19 epidemic was over at that time and lacked vigilance against the recurrence of the epidemic. Therefore, when the core patient with fever and pulmonary imaging changes was transferred from another hospital and admitted to our hospital, the patient's symptoms were considered to be associated with other conditions as the possibility of COVID-19 was arbitrarily ruled out. Moreover, medical staff did not have enough knowledge of COVID-19 or the hospital's relevant rules and regulations, especially those in the departments with low correlation with COVID-19.
To date, there is no available and effective antiviral treatment for COVID-19 patients other than supporting care[15]. Controlling population mobility and thus cutting off the transmission route is still the most effective way to prevent and control the spread of the epidemic, which has been effectively confirmed in the early battle against COVID-19[16]. Therefore, following the recurrence of epidemic, moderate crowd control policies were again restored, such as banning eating in restaurants, closing public places, and taking new quarantine and detection measures of entry personnel, also known as “14 + 7 + 14”. The latter stands for 14 d of centralized isolation and 2 times of nucleic acid detection, and 7 d of centralized isolation and one time of nucleic acid detection, which should be carried out at the entry place and the local region, respectively, followed by 14 d of home isolation and observation that should be implemented and incorporated into the grid management of the local community. Home isolation was based on the principle “one person, one house”, and those who did not meet the requirements were required to continue centralized isolation for 14 d. The supervision was jointly conducted by the local public security and the community.
Close contacts of the core patient were immediately isolated and subjected to related tests, including temperature, whole blood cell analysis, pulmonary computed tomography (CT) scan, nucleic acid, and antibodies of SARS-CoV-2. The inpatient building where the in-hospital infection had occurred was completely emptied, sealed off, and disinfected. In addition to inquiring on epidemiological history and initial symptoms, “five tests”, namely temperature, whole blood cell analysis, pulmonary CT scan (except for special groups, such as pregnant women and children), nucleic acid, and antibodies of SARS-CoV-2, were necessary for admission of all patients and their family caregivers. If emergency patients did not complete “five tests”, they needed to be admitted to a single room in the buffer zone and could be transferred to the general ward only after COVID-19 was excluded. Three-grade prevention measures are quite indispensable in the buffer zone to avoid SARS-CoV-2 infection in clinical practice. The detection ability of SARS-CoV-2 nucleic acid in our hospital has been greatly enhanced, and the results could be obtained in only 6 h. Therefore, the buffer zone had sufficient capacity to receive emergency patients.
In principle, family caregivers are not allowed in our hospital during this special period. In case of need, one family caregiver, who is designated as a fixed caregiver, must complete “five tests” before admission. All general wards have been transformed into single rooms with independent toilets. Patients or their family caregivers can pay online bills, order meals, and purchase daily necessities through a phone app without leaving a room. These items are delivered and distributed by hospital staff. Patients without special needs are not allowed to leave the room, and visitors are refused. Each general ward is under 24-h closed management, and the access of personnel is strictly controlled and supervised by security guards. The auxiliary inspections are carried out in different time periods by an appointment system. All of the above measures are implemented to limit the mobility of admitted patients and their family caregivers across different rooms and wards and to avoid personnel aggregation in public places. The public areas in the hospital are regularly and thoroughly disinfected. After admission to the general wards, the temperature is daily measured, while whole blood cell analysis, pulmonary CT scan, nucleic acid, and antibodies of SARS-CoV-2 are regularly performed in all patients to further exclude COVID-19. All medical staff in our hospital underwent screening on nucleic acid and antibodies of SARS-CoV-2, which were conducive to exclude asymptomatic carriers and prevent further in-hospital transmission[17,18]. All these efforts were made with the aim to break the transmission chain in the hospital and make a trade-off between resuming work and preventing in-hospital infection. Looking carefully from the history of human coronaviruses, we may have found the answers we were searching from existing experiences and lessons, which might give us some hint on future studies[14,18-20].
The 1-to-87 in-hospital infection has led medical staff to attach great importance to the recurrence of the COVID-19 epidemic. Adequate learning, training, and assessment enable medical staff to understand fully COVID-19 and master the relevant rules and regulations so as to avoid the recurrence of similar in-hospital infections. The learning, training, and assessment should be periodically repeated. Although there is vaccination hesitancy in the early clinical application of the vaccine, universal vaccination will be the most effective measures to prevent large COVID-19 outbreaks again in the future. At the moment, studies on effectiveness, timeliness, and safety of SARS-CoV2 vaccine are needed, because the most promising incentives for improving the likelihood of vaccination uptake is the vaccine proved to be effective and available[21]. It is necessary for medical staff to be vaccinated with SARS-CoV2 vaccine to protect themselves and prevent hospital transmission.
This in-hospital recurrence of COVID-19 in Heilongjiang province further deepens our understanding and knowledge of SARS-CoV-2 and infectivity of COVID-19. A detailed and accurate understanding of different causes for the recurrence of the epidemic at different levels, including city, hospital, and medical staff, can help to improve the prevention and control of COVID-19 and be used as a valuable reference for other medical staff.
Taking the possibility of long co-existence of SARS-CoV-2 with human beings into consideration, this work should be continuously carried out and improved. More practices and experiences are needed to achieve a perfect balance between resuming work and preventing in-hospital infection recurrence.
We are grateful to all colleagues who worked with us in the coronavirus disease 2019 treatment center of Heilongjiang Province and all those who provided selfless advice and help for this article. We pay tribute to the medical staff who lost their lives in the national fight against the epidemic. Data and information in this article mainly came from the official website of the Health Commission of Heilongjiang Province. http://wsjkw.hlj.gov.cn/.
Manuscript source: Unsolicited manuscript
Specialty type: Virology
Country/Territory of origin: China
Peer-review report’s scientific quality classification
Grade A (Excellent): 0
Grade B (Very good): 0
Grade C (Good): C
Grade D (Fair): 0
Grade E (Poor): 0
P-Reviewer: Vigano M S-Editor: Wang JL L-Editor: Filipodia P-Editor: Li JH
1. | Wu JT, Leung K, Leung GM. Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study. Lancet. 2020;395:689-697. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 3012] [Cited by in F6Publishing: 2460] [Article Influence: 615.0] [Reference Citation Analysis (0)] |
2. | Beeching NJ, Fletcher TE, Beadsworth MBJ. Covid-19: testing times. BMJ. 2020;369:m1403. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 118] [Cited by in F6Publishing: 98] [Article Influence: 24.5] [Reference Citation Analysis (0)] |
3. | Qiu G, Gai Z, Tao Y, Schmitt J, Kullak-Ublick GA, Wang J. Dual-Functional Plasmonic Photothermal Biosensors for Highly Accurate Severe Acute Respiratory Syndrome Coronavirus 2 Detection. ACS Nano. 2020;14:5268-5277. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 774] [Cited by in F6Publishing: 647] [Article Influence: 161.8] [Reference Citation Analysis (0)] |
4. | Xiao AT, Tong YX, Zhang S. False negative of RT-PCR and prolonged nucleic acid conversion in COVID-19: Rather than recurrence. J Med Virol. 2020;92:1755-1756. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 352] [Cited by in F6Publishing: 356] [Article Influence: 89.0] [Reference Citation Analysis (0)] |
5. | Li Y, Yao L, Li J, Chen L, Song Y, Cai Z, Yang C. Stability issues of RT-PCR testing of SARS-CoV-2 for hospitalized patients clinically diagnosed with COVID-19. J Med Virol. 2020;92:903-908. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 394] [Cited by in F6Publishing: 443] [Article Influence: 110.8] [Reference Citation Analysis (0)] |
6. | Wu J, Liu J, Zhao X, Liu C, Wang W, Wang D, Xu W, Zhang C, Yu J, Jiang B, Cao H, Li L. Clinical Characteristics of Imported Cases of Coronavirus Disease 2019 (COVID-19) in Jiangsu Province: A Multicenter Descriptive Study. Clin Infect Dis. 2020;71:706-712. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 324] [Cited by in F6Publishing: 407] [Article Influence: 101.8] [Reference Citation Analysis (1)] |
7. | Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, Wang B, Xiang H, Cheng Z, Xiong Y, Zhao Y, Li Y, Wang X, Peng Z. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. 2020;323:1061-1069. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 14113] [Cited by in F6Publishing: 14518] [Article Influence: 3629.5] [Reference Citation Analysis (0)] |
8. | Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, Ren R, Leung KSM, Lau EHY, Wong JY, Xing X, Xiang N, Wu Y, Li C, Chen Q, Li D, Liu T, Zhao J, Liu M, Tu W, Chen C, Jin L, Yang R, Wang Q, Zhou S, Wang R, Liu H, Luo Y, Liu Y, Shao G, Li H, Tao Z, Yang Y, Deng Z, Liu B, Ma Z, Zhang Y, Shi G, Lam TTY, Wu JT, Gao GF, Cowling BJ, Yang B, Leung GM, Feng Z. Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia. N Engl J Med. 2020;382:1199-1207. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 10402] [Cited by in F6Publishing: 9174] [Article Influence: 2293.5] [Reference Citation Analysis (0)] |
9. | Lai CC, Shih TP, Ko WC, Tang HJ, Hsueh PR. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges. Int J Antimicrob Agents. 2020;55:105924. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 3736] [Cited by in F6Publishing: 3119] [Article Influence: 779.8] [Reference Citation Analysis (0)] |
10. | Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Z, Yu T, Xia J, Wei Y, Wu W, Xie X, Yin W, Li H, Liu M, Xiao Y, Gao H, Guo L, Xie J, Wang G, Jiang R, Gao Z, Jin Q, Wang J, Cao B. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497-506. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 32663] [Cited by in F6Publishing: 29419] [Article Influence: 7354.8] [Reference Citation Analysis (3)] |
11. | Liu Y, Li J, Feng Y. Critical care response to a hospital outbreak of the 2019-nCoV infection in Shenzhen, China. Crit Care. 2020;24:56. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 71] [Cited by in F6Publishing: 65] [Article Influence: 16.3] [Reference Citation Analysis (0)] |
12. | Assiri A, McGeer A, Perl TM, Price CS, Al Rabeeah AA, Cummings DA, Alabdullatif ZN, Assad M, Almulhim A, Makhdoom H, Madani H, Alhakeem R, Al-Tawfiq JA, Cotten M, Watson SJ, Kellam P, Zumla AI, Memish ZA; KSA MERS-CoV Investigation Team. Hospital outbreak of Middle East respiratory syndrome coronavirus. N Engl J Med. 2013;369:407-416. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 888] [Cited by in F6Publishing: 897] [Article Influence: 81.5] [Reference Citation Analysis (0)] |
13. | Oboho IK, Tomczyk SM, Al-Asmari AM, Banjar AA, Al-Mugti H, Aloraini MS, Alkhaldi KZ, Almohammadi EL, Alraddadi BM, Gerber SI, Swerdlow DL, Watson JT, Madani TA. 2014 MERS-CoV outbreak in Jeddah--a link to health care facilities. N Engl J Med. 2015;372:846-854. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 340] [Cited by in F6Publishing: 341] [Article Influence: 37.9] [Reference Citation Analysis (0)] |
14. | Dwosh HA, Hong HH, Austgarden D, Herman S, Schabas R. Identification and containment of an outbreak of SARS in a community hospital. CMAJ. 2003;168:1415-1420. [PubMed] [Cited in This Article: ] |
15. | de Wit E, van Doremalen N, Falzarano D, Munster VJ. SARS and MERS: recent insights into emerging coronaviruses. Nat Rev Microbiol. 2016;14:523-534. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 2157] [Cited by in F6Publishing: 2223] [Article Influence: 277.9] [Reference Citation Analysis (0)] |
16. | Kraemer MUG, Yang CH, Gutierrez B, Wu CH, Klein B, Pigott DM; open COVID-19 data working group; du Plessis L, Faria NR, Li R, Hanage WP, Brownstein JS, Layan M, Vespignani A, Tian H, Dye C, Cauchemez S, Pybus OG, Scarpino SV. The effect of human mobility and control measures on the COVID-19 epidemic in China. medRxiv. 2020;. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 39] [Cited by in F6Publishing: 23] [Article Influence: 5.8] [Reference Citation Analysis (0)] |
17. | Black JRM, Bailey C, Przewrocka J, Dijkstra KK, Swanton C. COVID-19: the case for health-care worker screening to prevent hospital transmission. Lancet. 2020;395:1418-1420. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 299] [Cited by in F6Publishing: 279] [Article Influence: 69.8] [Reference Citation Analysis (0)] |
18. | Lee H, Heo JW, Kim SW, Lee J, Choi JH. A Lesson from Temporary Closing of a Single University-affiliated Hospital owing to In-Hospital Transmission of Coronavirus Disease 2019. J Korean Med Sci. 2020;35:e145. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 4.8] [Reference Citation Analysis (0)] |
19. | World Health Organization. Middle East respiratory syndrome coronavirus (MERS-CoV). Available from: http://www.who.int/emergencies/mers-cov/en/. [Cited in This Article: ] |
20. | Wang H, Kang K, Gao Y, Yang B, Li J, Wang L, Bi Y, Yu KJ, Dai QQ, Zhao MY. Remote nursing training model combined with proceduralization in the intensive care unit dealing with patients with COVID-19. World J Clin Cases. 2021;9:999-1004. [PubMed] [DOI] [Cited in This Article: ] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis (0)] |
21. | Taylor S, Landry CA, Paluszek MM, Groenewoud R, Rachor GS, Asmundson GJG. A Proactive Approach for Managing COVID-19: The Importance of Understanding the Motivational Roots of Vaccination Hesitancy for SARS-CoV2. Front Psychol. 2020;11:575950. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 168] [Cited by in F6Publishing: 186] [Article Influence: 46.5] [Reference Citation Analysis (0)] |